To further validate whether the tumor-derived RGS5 switches its function from inhibiting inflammation to promoting inflammation, Lenti-RGS5 was infected into and expressed in the breast cancer cells (Fig. 6E, F). Here, RGS5 is linked to breast carcinoma.